Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Preclinical studies suggest that NAC administered before or concurrently with cyclophosphamide may reduce acrolein-mediated toxicity, which mediates the side effects associated with cyclophosphamide use, including cardiotoxicity, liver damage and immunosuppression (50)
Avion BioLabs supplies research-use-only materials and makes no medical claims based on these references
Y., Chen, H
BPC-157 holds no Health Canada market authorization for any human or veterinary application
US$ 24.66
US$ 22.53
US$ 24.58
